senadex
stirolbiofarm baltikum sia - senų lapų (cassia senna) standartizuotas sausasis ekstraktas (77-94,5:1) - tabletės - 70 mg - contact laxatives
senefol
pharmaceutical laboratory labofarm - senų (cassia senna/cassia angustifolia) lapai ir vaisiai - tabletės - 300 mg - senna glycosides
senŲ lapai švf
Švenčionių vaistažolės uab - senų (senna) lapai - vaistažolių arbata - 1 g/g - contact laxatives
caspofungin sandoz
sandoz d.d. - kaspofunginas - milteliai infuzinio tirpalo koncentratui - 50 mg; 70 mg - caspofungin
dalvocans
zentiva k.s. - kaspofunginas - milteliai infuzinio tirpalo koncentratui - 50 mg; 70 mg - caspofungin
druniler
sandoz d.d. - febuksostatas - plėvele dengtos tabletės - 80 mg; 120 mg - febuxostat
flavamed
berlin-chemie ag (menarini group) - ambroksolio hidrochloridas - geriamasis tirpalas - 30 mg/5 ml - ambroxol
kanilad
medochemie ltd. - lakozamidas - plėvele dengtos tabletės - 200 mg; 150 mg; 100 mg; 50 mg - lacosamide
linoladiol n
dr. august wolff gmbh & co. kg arzneimittel - estradiolis - kremas - 100 µg/g; 0,1 mg/g - estradiol
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresantai - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.